Petition for Prior Approval of Sartorius Stedim Biotech S.A.’s Proposed Acquisition of Novasep Process SAS’s Chromatography Equipment Business

Sartorius Stedim Biotech S.A. (‘‘Sartorius’’) has petitioned the Federal Trade Commission (‘‘FTC’’ or ‘‘Commission’’) for approval of its acquisition of the chromatography equipment business of Novasep Process SAS. Sartorius was the FTC-approved divestiture buyer in 2020, when the FTC required Danaher Corporation to divest assets as a condition of acquiring General Electric’s biopharmaceutical business, which included chromatography assets. Sartorius agreed to obtain the Commission’s prior approval if it proposed to acquire Novasep’s chromatography business.